Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Express Scripts
Mallinckrodt
Citi
Boehringer Ingelheim

Generated: June 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Adare Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2014)

« Back to Dashboard

Adare Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2014)

Docket ➤ Try a Free Trial Date Filed 2014-08-11
Court District Court, D. Delaware Date Terminated 2018-09-11
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Sherry R. Fallon
Parties ADARE PHARMACEUTICALS, INC.; APOTEX CORP.; APOTEX INC.; APTALIS PHARMATECH INC.; IVAX INTERNATIONAL GMBH; TEVA INTERNATIONAL GMBH
Patents 7,387,793; 7,790,199; 7,829,121; 9,375,410
Attorneys Andrea L. Cheek; Craig S. Summers; David A. Bilson; Douglas Edward McCann; Jay R. Deshmukh; John C. Phillips , Jr.; John R. Lane; Jonathan E. Singer; Karen M Cassidy; Megan C. Haney; Robert M. Oakes; Susan E. Morrison; Thomas P. Krzeminski; William R. Zimmerman
Firms Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Adare Pharmaceuticals, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for Adare Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-08-11 1 United States Patent Nos. 7,790,199 (“the ’199 patent”) and 7,829,121 (“the ’121 patent”) (collectively… This is an action for patent infringement under the Food and Drug and Patent Laws of the United States…companies to submit patent information to FDA “with respect to which a claim of patent infringement could…interest in and to the ’199 patent. A true and correct copy of the ’199 patent is attached hereto as Exhibit…interest in and to the ’121 patent. A true and correct copy of the ’121 patent is attached hereto as Exhibit External link to document
2016-12-08 111 analyzed whether certain patents (parent patents to the current patents-in-suit) were invalid for obviousness…alleging infringement of U.S. Patent Nos. 7,790,199 ("the '199 patent") and 7,829,121 ("… 1. The patents-in-suit The '199 patent issued on September 7, 2010…Relaxants" (collectively, "the patents-in-suit"). The patents-in-suit share a common specification…#39;199 patent was filed on September 24, 2008, and is a continuation of parent U.S. Patent No. 7,387,793 External link to document
2016-12-08 114 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,790,199; 7,829,121. (Attachments… 11 September 2018 1:14-cv-01038 830 Patent None District Court, D. Delaware External link to document
2018-08-03 128 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,410 . (Phillips, John) … 11 September 2018 1:14-cv-01038 830 Patent None District Court, D. Delaware External link to document
2018-09-11 143 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,410. (Attachments: # 1 … 11 September 2018 1:14-cv-01038 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
Moodys
AstraZeneca
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.